ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

In Brief: Cancer Act Renewal Nears, Appropriations Bills Lag; Interim Funding Likely For ’83 Fiscal Year

September 24, 1982

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

UCSD Cancer Center Breaks Ground for New Building

November 15, 2002

Afinitor Significantly Reduced Tumor Size In TSC-Related Renal Angiomyolipomas

January 25, 2013